27 March 2021 : Clinical Research
Use of the Water-Soluble Contrast Medium Gastrografin in Treatment of Adhesive Small Bowel Obstruction in Patients with and Without Chronic Radiation Enteropathy: A Single-Center Retrospective Study
Lili Gu1BCEF, Feng Zhu1BDE, Tingbin Xie1BCD, Dengyu Feng1BEF, Jianfeng Gong1BDEG, Ning Li2ABEFG*DOI: 10.12659/MSM.930046
Med Sci Monit 2021; 27:e930046
Table 8 Long-term outcomes for patients with and without Gastrografin challenge.
| GG challenge (n=30) | No GG challenge (n=30) | p Value | |
|---|---|---|---|
| Readmission for any cause, n (%) | 21 (70.0) | 24 (80.0) | 0.27 |
| Readmission for SBO, n (%) | 16 (53.0) | 13 (43.3) | 0.41 |
| Time to readmission for SBO (days) | 117.7±32.1 | 125±36.1 | 0.76 |
| Readmission with operation, n (%) | 6 (20.0) | 7 (23.3) | 0.35 |